anonymous
Guest
anonymous
Guest
Let’s hope!!! And, how about having them actually interview for the position?!? Their resumes are falsifically inflated. At the end of the day, they are only primary care reps that have little to show for.
Getting back on track to the topic of this thread...
Can anyone else envision a reorg with Respiratory around June of next year? More generics affecting the market, and given the fact that IC is now 50% Vaccines... Doesn't that say something? Could Trelegy go Syneos-only, like the old Breo team? GSK reps fold into VBU or be let go? Does GSK give a rep a choice between severence or new position? Not worried, just speculating. And I do think they need to do something to streamline their sales forces. It's chaotic.